Former Medical Device Maker CEO’s Securities Fraud Conviction Upheld

Mealey's (January 11, 2019, 1:44 PM EST) -- NEW ORLEANS — A Fifth Circuit U.S. Court of Appeals panel on Jan. 7 found no reversible error in a federal district court’s evidentiary rulings and jury instructions in the criminal trial of a medical device company’s former CEO for his alleged role in a fraudulent channel-stuffing scheme, affirming the district court’s conviction on charges of wire fraud, securities fraud and conspiracy to commit wire fraud and securities fraud (United States of America v. Michael Baker, No. 17-51034, 5th Cir.; 2019 U.S. App. LEXIS 623)....